We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
+19.62%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$7B
AUM Growth
+$1.45B
Cap. Flow
+$669M
Cap. Flow %
9.56%
Top 10 Hldgs %
35.33%
Holding
139
New
45
Increased
38
Reduced
14
Closed
33

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$143M
2
UNH icon
UnitedHealth
UNH
+$135M
3
DT icon
Dynatrace
DT
+$86.6M
4
OPEN icon
Opendoor
OPEN
+$75.7M
5
EXAS
Exact Sciences
EXAS
+$73.9M

Top Sells

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$106M
2
APH icon
Amphenol
APH
+$99.8M
3
GAP
The Gap Inc
GAP
+$96.2M
4
AMZN icon
Amazon
AMZN
+$95.6M
5
CPRT icon
Copart
CPRT
+$71M

Sector Composition

Rank Sector Weight
1 Technology 22.5%
2 Healthcare 21.05%
3 Consumer Discretionary 16.78%
4 Industrials 15.25%
5 Communication Services 11.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASTRW
101
DELISTED
Astra Space, Inc. Warrant
ASTRW
$675K 0.01%
+499,999
New +$619K
OBIO icon
102
Orchestra BioMed
OBIO
$254M
$641K 0.01%
50,000
– –
SNPR.WS
103
DELISTED
Tortoise Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary shar
SNPR.WS
$463K 0.01%
+162,499
New +$367K
SPFR.U
104
DELISTED
JAWS Spitfire Acquisition Corp Units, each consisting of one Class A ordinary share, and one-fourth
SPFR.U
$139K ﹤0.01%
+12,590
New +$136K
TMPMW
105
DELISTED
Turmeric Acquisition Corp. Warrant
TMPMW
$121K ﹤0.01%
+66,666
New +$103K
APH icon
106
Amphenol
APH
$209B
– –
-3,685,640
Closed -$99.8M
AUPH icon
107
Aurinia Pharmaceuticals
AUPH
$2.11B
– –
-735,500
Closed -$10.8M
CALC icon
108
CalciMedica
CALC
$10.9M
– –
-7,836
Closed -$1.39M
CHRS icon
109
Coherus Oncology
CHRS
$196M
– –
-238,100
Closed -$4.37M
CLOV icon
110
Clover Health Investments
CLOV
$2.51B
– –
-3,678,000
Closed -$45.8M
CPRT icon
111
Copart
CPRT
$27.5B
– –
-2,699,640
Closed -$71M
GOOG icon
112
Alphabet (Google) Class C
GOOG
$4.32T
– –
-820,480
Closed -$60.3M
HRMY icon
113
Harmony Biosciences
HRMY
$2.24B
– –
-12,500
Closed -$424K
HUM icon
114
Humana
HUM
$46.2B
– –
-162,100
Closed -$67.1M
KYMR icon
115
Kymera Therapeutics
KYMR
$8.94B
– –
-110,230
Closed -$3.56M
LGND icon
116
Ligand Pharmaceuticals
LGND
$6.36B
– –
-123,774
Closed -$7.36M
MRNA icon
117
PUT
Moderna
MRNA
$23.6B
– –
-111,400
Closed -$7.88M
NVAX icon
118
Novavax
NVAX
$1.31B
– –
-80,914
Closed -$8.77M
ORGN
119
DELISTED
Origin Materials
ORGN
– –
-57,197
Closed -$17.1M
PYPL icon
120
PayPal
PYPL
$50.5B
– –
-538,700
Closed -$106M
RSG icon
121
Republic Services
RSG
$65.7B
– –
-527,015
Closed -$49.2M
TJX icon
122
TJX Companies
TJX
$178B
– –
-893,000
Closed -$49.7M
GAP
123
The Gap Inc
GAP
$7.37B
– –
-5,650,060
Closed -$96.2M
XYZ
124
Block Inc
XYZ
$47.5B
– –
-332,550
Closed -$54.1M
KLRS
125
Kalaris Therapeutics
KLRS
$96.8M
– –
-1,696
Closed -$1.07M
2 3 4
5
6

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Suvretta Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Suvretta Capital Management held 139 positions worth $7B, up 26% from $5.55B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Suvretta Capital Management deployed $669M of net new capital in Q4 2020, opening 45 new positions and adding to 38 existing holdings. Its largest new stake was Dynatrace: 2,179,910 shares worth $94.3M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Amazon, an estimated $95.6M trimmed.

  • Suvretta Capital Management's largest Q4 2020 buy was Dynatrace: 2,179,910 shares worth $94.3M.
  • Suvretta Capital Management added most to Netflix in Q4 2020, an estimated $143M increase.
  • Suvretta Capital Management's biggest Q4 2020 reduction was Amazon, cutting an estimated $95.6M.
  • Suvretta Capital Management fully exited PayPal in Q4 2020, selling an estimated $106M.
  • Suvretta Capital Management's ten largest holdings make up 35% of its $7B portfolio in Q4 2020.
  • Suvretta Capital Management opened 45 new positions and closed 33 in Q4 2020.
  • Suvretta Capital Management's portfolio value rose 26% quarter-over-quarter to $7B.

Based on Suvretta Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.